NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC.

6 Months Ended

Jul. 31, 2020

NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC.

NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC.

NOTE 12 – NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO THE STOCKHOLDERS OF ARGAN, INC.

Basic and diluted net income (loss) per share amounts are computed as follows (shares in thousands except in notes (1) below the charts):

	Three Months Ended July 31,
	2020		2019
Net income attributable to the stockholders of Argan, Inc.	$	5,609	$	1,154
Weighted average number of shares outstanding – basic		15,653		15,633
Effect of stock awards (1)		135		124
Weighted average number of shares outstanding – diluted		15,788		15,757
Net income per share attributable to the stockholders of Argan, Inc.
Basic	$	0.36	$	0.07
Diluted	$	0.36	$	0.07

(1) For the three months ended July 31, 2020 and 2019, the weighted average numbers of shares determined on a dilutive basis exclude the effects of restricted stock units and antidilutive stock options covering aggregates of 761,000 and 530,000 shares of common stock, respectively.

	Six Months Ended July 31,
	2020		2019
Net income (loss) attributable to the stockholders of Argan, Inc.	$	4,846	$	(28,646)
Weighted average number of shares outstanding – basic		15,648		15,608
Effect of stock awards (1)		119		—
Weighted average number of shares outstanding – diluted		15,767		15,608
Net income (loss) per share attributable to the stockholders of Argan, Inc.
Basic	$	0.31	$	(1.84)
Diluted	$	0.31	$	(1.84)

(1)   For the six months ended July 31, 2020, the weighted average number of shares determined on a dilutive basis excludes the effects of restricted stock units and antidilutive stock options covering an aggregate of 831,000 shares of common stock. For the six months ended July 31, 2019, all common stock equivalents, which covered 1,135,067 shares of common stock, were considered to be antidilutive as the Company incurred a net loss.